Pregnancy and Birth

2000 September 17-21  Tblisi, Georgia Xth World Congress on Gestational Trophoblastic Disease Contact: chark@access.sanet.geSeptember 20-21 London, UK Psychosexual medicine in practice Contact: http://www.med.ic.ac.uk/dp/dpshSeptember 20-23 Leuven, Belgium From Gamete to Newborn Contact: http://www.gamete-to-newborn.orgOctober 04-06 London, UK Medical problems facing obstetricians and  gynaecologists in pregnancy Contact: http://www.med.ic.ac.uk/dp/dpsh/default.htm  or sympreg@ic.ac.ukOctober 04-07 Zagreb, Croatia 10th World Congress Ultrasound in Obstetrics and Gynaecology (ISUOG) Contact: http://www.hko.hr or http://www.isuog.orgOctober 12 London, UK Maternal mental health and the child Contact: http://www.med.ic.ac.uk/dp/dpsh October 19-21 Paris, France 9th Congress of the European Society for  Gynaecological Endoscopy (ESGE) Contact: http://www.convergences.fr/uk/aesge.htm October 20 London, UKWomen and children with HIV and AIDS Contact: http://www.med.ic.ac.uk/dp/dpsh October 21-26 San Diego, CA, USA 56th Annual Meeting of the American Society for Reproductive Medicine Contact: http://www.asrm.org October 22-25 Rome, Italy XXVth Annual Meeting of the International  UroGynecological Association (IUGA) Contact: http://www.iuga2000.com  October 28-30 Bruges, Belgium 3rd Congress of the European Society of Gynecology Contact: thomas@ocst.ucl.ac.be November 03-04 Halle/Saale, Germany Gynecologic surgery: from experience to  evidence-based medicine Contact: gerda.bertram@medizin.uni-halle.de November 14-19 Orlando, FL, USA Global Congress of Gynecologic Endoscopy  AAGL 29th Annual Meeting  Contact: http://aagl.com/aaglcal.htmNovember 23-26 Brussels, Belgium 5th World Congress on the Internet in Medicine (MEDNET 2000) Contact: http://www.mdf.be/mednet2000/index2.htm December 06-08 Florence, Italy 8th World Congress of Gynecological Endocrinology Contact: http://www.biomedicaltechnologies.com/cinteng.html 2001 March 28-31 Chicago, IL, USA 10th Annual ISGE Congress Contact: http://www.eventsintl.com/isge2001

Feasibility of laparoscopic myomectomy is now accepted even if the attention is still stressed on technical difficulties due to myoma location and size and difficulty in reapproximating the incision by laparoscopic suturing that requires perfect mastery of endoscopic suturing.

The objective of this manuscript is to study the pregnancy rate and the prognostic factors for conception after myomectomy carried out in cases of infertility.

A case of unicornuate uterus with cavitary non-communicating rudimentary horn suddenly revealing with acute abdomen is presented. The patient was managed by laparoscopic miniaccess hemihysterectomy.

Although diagnostic problems make it difficult to establish the extent of the male partner's contribution with certainty, a number of studies suggest that male problems represent the most common single defined cause of infertility.

Brief overview of human egg and embryo freezing. Discussion of merits of currently utilized cryopreservation protocols. Practical issues of cryopreservation with reference to egg or embryo selection, and thaw replacement protocols. Alternative cryopreservation technologies.

The frequency of chromosome aberration in spontaneous and induced abortions in the first three-month period of pregnancy has been presented in this study. The examination has been done in the period from 2001 till 2002 on the sample of 80 chorion and fetal tissue of 8-12 weeks of gestation.

This article discusses the nature of infertility treatment and its relation to infertile couples' desires for multiple pregnancy, the special risks of iatrogenic multiple pregnancy (IMP), the informed consent process in assisted reproductive technology, and the ethical dilemma of IMP and methods for its resolution.

A 35-year-old nulliparous woman with a giant uterine myoma is described. During the past three years she had developed a intramural myoma and a subserous myoma. Although the lesions were excised, both reappeared and were treated with GnRH analogues for 6 months.

Telemedicine is the electronic transmission of health information for the delivery of clinical care from a distance. Today it is increasingly used to provide efficiencies in the delivery of women’s health care.

Over the past two decades, an epidemic of multiple pregnancies has taken place in the developed world due to the widespread use of assisted reproductive technology. The general public has come to accept the phenomenon of higher order multiple as being a normal occurrence, expecting a good outcome for both the fetuses and the mother.

Uteroplacental Bleeding Disorders During Pregnancy: Do Missing Paternal Characteristics Influence Risk?

Patients suffering from diseased and injured organs may be treated with transplanted organs. However, there is a severe shortage of donor organs which is worsening yearly due to the aging population. Scientists in the field of tissue engineering apply the principles of cell transplantation, materials science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues.

Molecular Mechanisms in Uterine Epithelium during Trophoblast Binding:The Role of Small GTPase RhoA in Human Uterine Ishikawa Cells

The sperm penetration assay (SPA) is used to predict the fertilizing capacity of sperm. Thus, some programs rely on SPA scores to formulate insemination plans in conjunction with in-vitro fertilization (IVF) cycles. The purpose of this study was to evaluate if a relationship exists between SPA scores and polyspermy rates during conventional IVF cycles.

About 30–40% of male infertility is due to unknown reasons. Genetic contributions to the disruption of spermatogenesis are suggested and amongst the genetic factors studied, Y chromosome microdeletions represent the most common one. Screening for microdeletions in AZFa, b and c region of Y chromosome showed a big variation among different studies.

The publication of a report in Nature in 2004 by the Tilly group suggesting that mouse ovaries are capable of generating oocytes de novo post-natally, has sparked interest in a problem long thought to have been resolved from classical studies in a variety of mammalian species.

The safety and tolerability of a new highly purified, urine-derived human menopausal gonadotropin (hMG) preparation [Menopur(R)] was compared with a currently available hMG [Repronex (R)] in women undergoing in vitro fertilization (IVF).

Central to any consideration of techniques in the IVF lab is the quality of the gametes that the lab has to work with. Usually there is little opportunity to modify the basic quality of sperm, however, the oocyte is a direct biological end product of ovarian super-ovulation as commonly conducted in human IVF therapy.

Plasma Homocysteine, Fasting Insulin, and Serum Androgens as a Function of Sonographic Ovarian Features in Women Feferred for Infertility Assessement

The first thing that usually comes to mind when people hear the term, "infertility treatment," is the risk of multiple births. This worry has been fueled by the recent highly publicized multiple births in Iowa and Texas.

Suppose you want to find a good website about gynaecology and/or obstetrics and you try the search engine Google, you will get 1,060,000 hits for gynaecology and 1,260,000 for obstetrics. Both give as the first link www.obgyn.net, ‘the Universe of Women’s Health’.

When a graafian follicle ruptures to release an oocyte, it is transformed into a corpus luteum. The corpus luteum is lined by a layer of granulose cells which rapidly become vascularized; some of these thin-walled vessels can rupture. This causes bleeding into the corpus luteum, resulting in the formation of a hemorrhagic cyst of the ovary.

In 1935 Drs Stein and Leventhal described 7 women with irregular periods (oligomenorrhea), increased body hair (hirsutism) and obesity, who at the time of surgery were found to have enlarged ovaries with a smooth "pearly white" appearance.

The purpose of this study is to determine if low-dose aspirin improved ovarian stimulation, endometrial response, or IVF pregnancy rates in our program.

Dutch researchers find first evidence that female human embryos adjust the balance of X chromosomes before implantation in the womb. Results have implications for in vitro fertilisation and embryonic stem cell research

Ultra-fast freezing of ovarian tissue from women who have lost their fertility as a result of cancer treatment can lead to it being used in transplants with the same success rate as fresh tissue, a researcher told the 25th annual conference of the European Society of Human Reproduction and Embryology.

For the first time, researchers have been able to identify genetic predictors of the potential success or failure of IVF treatment in blood. Dr. Cathy Allen, from the Rotunda Hospital, Dublin, Ireland, told the 25th annual conference of the European Society of Human Reproduction and Embryology today (Wednesday 1 July) that her research would help understand why IVF works for some patients but not for others.

Ms Vanneste and her team studied each cell from 23 three or four day-old IVF embryos from young (less than 35 years old), fertile couples who had asked for preimplantation genetic diagnosis (PGD). PGD is carried out where one or both parents have a known genetic abnormality, in this case an X-linked disorder or the microdeletions (loss of a tiny piece of a chromosome) that can cause such disorders as the cancer predisposition syndrome neurofibromatosis type 1.

Twin deliveries after assisted reproductive technology (ART) have fallen below 20% for the first time in Europe according to the tenth report summarising data on ART in Europe, which was presented at the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam today (Wednesday).